Reality show-style competition showcases new diabetes business ideas with potential fundraisers as part of ADA 83rd Scientific sessions
San Diego, June 24, 2023 /PRNewswire/ – Today the American Diabetes Association® (ADA) announced the winner of the opening race in 83rd American Diabetes Association (ADA) Scientific Sessions at San Diego, California The inaugural Innovation Challenge highlighted six business concepts for diabetes care with the goal of connecting innovators and start-up companies with transformative solutions and ideas. The winning minutia Oregon Health and Science University And Go pen It offers three unique and impactful solutions to various diabetes challenges.
The competition comes when it’s more than that. 37.3 million Americans They are affected by diabetes and Digital health innovations are on the rise. To solve the development of the disease with technological advances. As a result, diabetes initiation continues to be a growing market.
“This pitch competition aims to accelerate the path from concept to commercialization of new ways of looking at diabetes care. Our goal is to support innovation and expose these life-changing ideas to partners who can provide the resources and guidance needed to move them forward,” said ADA CEO Charles Chuck Henderson. “We congratulate the winners for their work and celebrate all that lies ahead.”
The Innovation Challenge included six finalists selected from a competitive pool of applicants. During the discussion, participants had five minutes each to present their ideas, followed by questions from the judges. The judges represented three potential funders: Helmsley Charitable Trust, Swiss Diabetes Venture Fund and Startup Health. The final three contestants, voted by the live audience, had a personal presentation with the judges to determine the winner.
- Winner: Go pen – GO-Pen will be the only insulin pen where people with diabetes can purchase insulin in vials and fill their own reservoirs with the insulin pen.
- Winner: Mintia – Developing the first widely available functional cure for type 1 diabetes with subcutaneous insulin-producing immune cells controlled in real-time by proprietary sensors.
- Winner: Oregon Health and Science University – Remote and proximal interventions occur across systems such as health care, social services, home/neighborhood, schools, employers, and communities to improve diabetes outcomes.
- Finalist: Angel Watch Company – Novel technology using a cellular device designed specifically for children as a bridge between a child’s CGM device and a parent’s phone.
- Last Player: Devin – A four-part virtual care model (1) mobile-first consumer experiences (2) virtual, synchronous medical appointments with female cardiologists (3) remote monitoring (4) labs and at-home support for women with gestational diabetes.
- Final Player: Neurovalence – The first neurostimulation device is to use non-invasive electrical stimulation to treat T2DM. It provides a drug-free, safe and low-cost medical intervention that effectively treats the underlying cause of T2DM in the patient’s home and is administered for only 60 minutes per day.
Look here. Learn more about more challenging quizzes. Stay tuned for more information on applications for next year’s Innovation Challenge.
Scientific sessions about the ADA
83 of the ADArd The scientific sessions of the world’s largest scientific meeting focused on diabetes research, prevention and care will be held in San Diego, California On June 23-26. More than 12,000 renowned physicians, scientists, and health care professionals from around the world are expected to unveil the latest research, treatment recommendations, and advances in the physical and virtual cures for diabetes. Attendees will gain exclusive access to thousands of original research presentations and engage in stimulating and engaging exchanges with leading diabetes experts. Join the Scientific Sessions conversation on social media using #ADA2023.
About the American Diabetes Association
The American Diabetes Association (ADA) is the nation’s leading voluntary health organization fighting to bend the curve on the diabetes epidemic and help people with diabetes thrive. For 82 years, the ADA has made breakthroughs and research into medicine to treat, manage, and prevent diabetes. Through advocacy, program development and education, we aim to improve the quality of life for the more than 133 million Americans living with diabetes or pre-diabetes. Diabetes brings us together. What we do next keeps us connected for life. To learn more or get involved, visit us at Diabetes.org Or call 1-800-DIABETES (1-800-342-2383). Join the fight with us on Facebook (American Diabetes Association), Spanish Facebook (American Diabetes AssociationLinkedInAmerican Diabetes Association), Twitter (@AmDiabetesAssnand Instagram (@AmDiabetesAssn).
Source American Diabetes Association